Aspira Women's Health Inc. (AWHL) stock
AWHLOTCIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31
$0.22−0.01 (-2.61%)
Close on Oct 19, 2026Market cap $9.91MP/E –Yield –
Aspira Women's Health ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
Aspira Women's Health's ebitda for the twelve months ending Jun 30, 2026 was -$6.73M. For fiscal 2025 it was -$7.80M. The highest annual figure on record is -$7.80M in fiscal 2025.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$7.80M | – |
| FY2024 | Dec 31, 2024 | -$16.19M | – |
| FY2023 | Dec 31, 2023 | -$18.65M | – |
| FY2022 | Dec 31, 2022 | -$30.87M | – |
| FY2021 | Dec 31, 2021 | -$32.29M | – |
| FY2020 | Dec 31, 2020 | -$17.72M | – |
| FY2019 | Dec 31, 2019 | -$14.95M | – |
| FY2018 | Dec 31, 2018 | -$10.66M | – |
| FY2017 | Dec 31, 2017 | -$9.66M | – |
| FY2016 | Dec 31, 2016 | -$14.23M | – |
| FY2015 | Dec 31, 2015 | -$18.96M | – |
| FY2014 | Dec 31, 2014 | -$19.07M | – |
| FY2013 | Dec 31, 2013 | -$8.79M | – |
| FY2012 | Dec 31, 2012 | -$9.33M | – |
| FY2011 | Dec 31, 2011 | -$17.56M | – |
| FY2010 | Dec 31, 2010 | -$14.49M | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$1.80M | – |
| Q1 FY2026 | Mar 31, 2026 | -$2.16M | – |
| Q4 FY2025 | Dec 31, 2025 | -$1.25M | – |
| Q3 FY2025 | Sep 30, 2025 | -$1.53M | – |
| Q2 FY2025 | Jun 30, 2025 | -$1.80M | – |
| Q1 FY2025 | Mar 31, 2025 | -$3.23M | – |
| Q4 FY2024 | Dec 31, 2024 | -$3.42M | – |
| Q3 FY2024 | Sep 30, 2024 | -$3.72M | – |
| Q2 FY2024 | Jun 30, 2024 | -$4.37M | – |
| Q1 FY2024 | Mar 31, 2024 | -$4.68M | – |
| Q4 FY2023 | Dec 31, 2023 | -$4.10M | – |
| Q3 FY2023 | Sep 30, 2023 | -$4.08M | – |
| Q2 FY2023 | Jun 30, 2023 | -$4.27M | – |
| Q1 FY2023 | Mar 31, 2023 | -$6.21M | – |
| Q4 FY2022 | Dec 31, 2022 | -$5.02M | – |
| Q3 FY2022 | Sep 30, 2022 | -$8.51M | – |
| Q2 FY2022 | Jun 30, 2022 | -$8.16M | – |
| Q1 FY2022 | Mar 31, 2022 | -$9.18M | – |
| Q4 FY2021 | Dec 31, 2021 | -$8.88M | – |
| Q3 FY2021 | Sep 30, 2021 | -$9.63M | – |
| Q2 FY2021 | Jun 30, 2021 | -$7.99M | – |
| Q1 FY2021 | Mar 31, 2021 | -$5.80M | – |
| Q4 FY2020 | Dec 31, 2020 | -$5.99M | – |
| Q3 FY2020 | Sep 30, 2020 | -$4.22M | – |
| Q2 FY2020 | Jun 30, 2020 | -$3.77M | – |
| Q1 FY2020 | Mar 31, 2020 | -$3.74M | – |
| Q4 FY2019 | Dec 31, 2019 | -$3.35M | – |
| Q3 FY2019 | Sep 30, 2019 | -$3.79M | – |
| Q2 FY2019 | Jun 30, 2019 | -$4.21M | – |
| Q1 FY2019 | Mar 31, 2019 | -$3.60M | – |
| Q4 FY2018 | Dec 31, 2018 | -$2.68M | – |
| Q3 FY2018 | Sep 30, 2018 | -$2.49M | – |
| Q2 FY2018 | Jun 30, 2018 | -$2.85M | – |
| Q1 FY2018 | Mar 31, 2018 | -$2.65M | – |
| Q4 FY2017 | Dec 31, 2017 | -$2.75M | – |
| Q3 FY2017 | Sep 30, 2017 | -$2.30M | – |
| Q2 FY2017 | Jun 30, 2017 | -$2.15M | – |
| Q1 FY2017 | Mar 31, 2017 | -$2.45M | – |
| Q4 FY2016 | Dec 31, 2016 | -$2.63M | – |
| Q3 FY2016 | Sep 30, 2016 | -$3.27M | – |
See a number that looks wrong?